-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Coya Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2022 to Q2 2024.
- Coya Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.24M, a 0.56% increase year-over-year.
- Coya Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$10.5M, a 3.25% increase year-over-year.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$7.9M, a 19.5% increase from 2022.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$9.81M, a 101% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)